Effect of intramammary injection of RbIL-8 on milk levels of somatic cell count, chemiluminescence activity and shedding patterns of total bacteria and S. aureus in Holstein cows with naturally infected-subclinical mastitis.
Summary The effect of intramammary injection of recombinant bovine interleukin-8 (rbIL-8, 1 mg/10 ml of saline) on quarter milk levels of somatic cell count (SCC), chemiluminescence (CL) activity and counts of total bacteria and Staphylococcus aureus (S. aureus) was investigated, using 10 Holstein cows with an early stage or a late stage of subclinical mastitis naturally infected with S. aureus. In the late-stage group, milk SCC and CL activity had significant rises with maximum levels at 6 h, following maintained high levels thereafter post-cytokine injection. The counts in milk total bacteria and S. aureus were insignificantly decreased, being increased back on day 7 post-cytokine injection. Thus, the cytokine was inefficient for the late-stage subclinical mastitis. However, in the early-stage group milk SCC and CL activity declined to under pre-injection levels on day 7 after marked and significant rises at 6 h and day 1 post-cytokine injection. The milk total bacterial count decreased significantly on days 0.25 and 2. Furthermore, the milk S. aureus count was decreased significantly on days 1, 2, 3 and 7 by the cytokine injection. These results suggest that the rbIL-8 has a potential as a therapeutic agent of the subclinical mastitis of dairy cows, if the cytokine is applied at an initial stage of infection.
Takahashi
H
H
Department of Production Animal Diseases, National Institute of Animal Health, Tsukuba 305-0856, Japan.
Komatsu
T
T
Hodate
K
K
Horino
R
R
Yokomizo
Y
Y
D000818:Animals; D002417:Cattle; D002452:Cell Count / Q000662:veterinary; D015169:Colony Count, Microbial / Q000662:veterinary; D005260:Female; D007267:Injections / Q000662:veterinary; D016209:Interleukin-8 / Q000008:administration & dosage / Q000627:therapeutic use*; D008163:Luminescent Measurements / Q000662:veterinary; D008321:Mammary Glands, Animal; D008414:Mastitis, Bovine / Q000188:drug therapy*; D008892:Milk / Q000166:cytology* / Q000382:microbiology*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000662:veterinary*; D013211:Staphylococcus aureus / Q000187:drug effects*; D016896:Treatment Outcome
D016209:Interleukin-8; D011994:Recombinant Proteins